MichaelDPradosMD

Oncology • San Francisco, CA

Neuro-Oncology

Professor Emeritus of Neurological Surgery, UCSF

Join to view full profile

Dr. Prados is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Prados' full profile

Already have an account?

Office
1450 3rd Street
San Francisco, CA 94158
Phone+1 415-476-7217

Fax+1 415-514-9792

Education & Training

Louisiana State University School of Medicine (Baton Rouge)Residency, Internal Medicine, 1975 - 1977
Louisiana State University School of MedicineInternship, Internal Medicine, 1974 - 1975
Louisiana State University School of Medicine in New OrleansClass of 1974

Certifications & Licensure

CA State Medical License 1985 - 2026
LA State Medical License 1974 - 1989
NM State Medical License 1978 - 1989
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

O(6)-Benzylguanine in Treating Patients With Malignant Glioma Start of enrollment: 1997 Jun 19
Completed
Phase 1
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma Start of enrollment: 1998 Mar 25
Completed
Phase 2
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma Start of enrollment: 1998 Oct 22
Completed
Phase 1, Phase 2
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma Start of enrollment: 2002 Jan 28
Completed
Phase 1
Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2002 Oct 23
Terminated
Phase 2
Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) Start of enrollment: 2004 Jan 01
Completed
Phase 1, Phase 2
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors Start of enrollment: 2004 Aug 01
Completed
Phase 2
Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma Start of enrollment: 2007 Sep 01
Completed
Phase 2
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas Start of enrollment: 2008 Aug 01
Completed
Phase 1
Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain Start of enrollment: 2010 Aug 01
Terminated
Phase 2
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide Start of enrollment: 2011 Oct 01
Terminated
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
Active, not recruiting
Phase 2
Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma Start of enrollment: 2014 Aug 01
Completed
Join now to see all

Publications & Presentations

PubMed

8 citations
Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers
Adam Autry, Ilwoo Park, Cassie Kline, H.-Y. Chen, Jeremy W. Gordon
AJNR. American Journal of Neuroradiology. 2021-01-01
5682 citations
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger E. McLendon, Allan H. Friedman, Darrell D. Bigner, Erwin G. Van Meir, Daniel J. Brat
Nature. 2008-10-23
86 citations
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.
James J. Vredenburgh, Timothy F. Cloughesy, Meghna Samant, Michael D. Prados, Patrick Y. Wen
The Oncologist. 2010-12-01

Journal Articles

Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy
Eugene I Hwang, Cassie Kline, Soonmee Cha, Michael Prados, Lindsay B Kilburn, Nalin Gupta, Roger J Packer, Suresh N Magge, Clinical Cancer Research

Press Mentions

Scientific Symposium Marks the Ten-Year Anniversary of the Pacific Pediatric Neuro-Oncology Consortium (PNOC) and FoundationMay 1st, 2023
5th Annual CBTTC Investigator Meeting – Note from the Executive Board ChairMay 29th, 2019
Researchers to Test Individualized Drug Cocktails for Kids' Brain TumorsAugust 30th, 2018
Join now to see all